Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Baldo

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
The Cochrane Database of Systematic Reviews|September 14, 2012
Antidepressants for patients with tinnitusPaolo Baldo, Carolyn Doree, Paola Molin, et al.
Expert Opinion on Drug Safety|February 25, 2014
Safety and efficacy evaluation of albumin-bound paclitaxelSara Cecco, Maria Aliberti, Paolo Baldo, et al.
Expert Opinion on Drug Safety|June 20, 2020
Pharmacovigilance of anti-cancer medicines: opportunities and challengesDiana Crestan, Marta Paulina Trojniak, Sara Francescon, et al.
Current Cancer Drug Targets|December 17, 2008
mTOR pathway and mTOR inhibitors as agents for cancer therapyPaolo Baldo, Sara Cecco, Elisa Giacomin, et al.
Cancer Medicine|August 3, 2022
Immune checkpoint inhibitors as first line in advanced melanoma: Evaluating progression-free survival based on reconstructed individual patient dataAndrea Ossato, Vera Damuzzo, Paolo Baldo, et al.
Recent Patents on Anti-Cancer Drug Discovery|August 1, 2019
Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Lung CancerAlessandra Bearz, Sara Cecco, Sara Francescon, et al.
Current Cancer Drug Targets|November 11, 2010
Cancer vaccines in phase II/III clinical trials: state of the art and future perspectivesSara Cecco, Elena Muraro, Elisa Giacomin, et al.
Tumori|March 10, 2010
Incidence of palmar-plantar erythrodysesthesia in pretreated and unpretreated patients receiving pegylated liposomal doxorubicinGianMaria Miolo, Paolo Baldo, Ettore Bidoli, et al.
Journal of Evaluation in Clinical Practice|March 24, 2007
A centralized Pharmacy Unit for cytotoxic drugs in accordance with Italian legislationPaolo Baldo, Antonella Bertola, Giancarlo Basaglia, et al.
Recent Patents on Anti-Cancer Drug Discovery|August 1, 2019
Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Cutaneous MelanomaDebora Basile, Camilla Lisanti, Maria A Pizzichetta, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
The Cochrane Database of Systematic Reviews|September 14, 2012
Antidepressants for patients with tinnitusPaolo Baldo, Carolyn Doree, Paola Molin, et al.
Expert Opinion on Drug Safety|February 25, 2014
Safety and efficacy evaluation of albumin-bound paclitaxelSara Cecco, Maria Aliberti, Paolo Baldo, et al.
Expert Opinion on Drug Safety|June 20, 2020
Pharmacovigilance of anti-cancer medicines: opportunities and challengesDiana Crestan, Marta Paulina Trojniak, Sara Francescon, et al.
Current Cancer Drug Targets|December 17, 2008
mTOR pathway and mTOR inhibitors as agents for cancer therapyPaolo Baldo, Sara Cecco, Elisa Giacomin, et al.
Cancer Medicine|August 3, 2022
Immune checkpoint inhibitors as first line in advanced melanoma: Evaluating progression-free survival based on reconstructed individual patient dataAndrea Ossato, Vera Damuzzo, Paolo Baldo, et al.
Recent Patents on Anti-Cancer Drug Discovery|August 1, 2019
Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Lung CancerAlessandra Bearz, Sara Cecco, Sara Francescon, et al.
Current Cancer Drug Targets|November 11, 2010
Cancer vaccines in phase II/III clinical trials: state of the art and future perspectivesSara Cecco, Elena Muraro, Elisa Giacomin, et al.
Tumori|March 10, 2010
Incidence of palmar-plantar erythrodysesthesia in pretreated and unpretreated patients receiving pegylated liposomal doxorubicinGianMaria Miolo, Paolo Baldo, Ettore Bidoli, et al.
Journal of Evaluation in Clinical Practice|March 24, 2007
A centralized Pharmacy Unit for cytotoxic drugs in accordance with Italian legislationPaolo Baldo, Antonella Bertola, Giancarlo Basaglia, et al.
Recent Patents on Anti-Cancer Drug Discovery|August 1, 2019
Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Cutaneous MelanomaDebora Basile, Camilla Lisanti, Maria A Pizzichetta, et al.
Pageof 4